483
University of Utah Cell Therapy and Regenerative MedicineFDA 483 - University of Utah Cell Therapy and Regenerative Medicine - July 13, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of the University of Utah Cell Therapy Facility in Salt Lake City, UT, identified a significant deficiency in the quality control unit's authority. Specifically, the Quality Supervisor was found to have reviewed and released batch records without adequate access to production activities or knowledge of process controls and specifications. This indicates a breakdown in the firm's quality oversight for its biological drug and HCT/P products.
- Inspection Date
- July 13, 2018
- Product Type
- Biologics
Open in Dashboard
ID · 024bfb8a-7cf4-4dd7-a0e9-00254b7159e7